Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice

Authors
Publication date
1 January 2017
Publisher
'Ovid Technologies (Wolters Kluwer Health)'
Doi

    Abstract

    Abstract We determined risk of virologic failure (VF) in individuals initiating tenofovir/emtricitabine/efavirenz as single versus multiple tablet regimens (MTR). We found no significant difference in the risk of VF, though did observe a trend toward more VF and M184 V mutations among persons initiating MTR. Temporal trends in care may have confounded results

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Sustaining member

      eScholarship - University of California

      redirect
      oaioai:escholarship.org:ark:/1303...
      Last time updated on 25/12/2021

      Crossref

      redirect
      oaiinfo:doi/10.1097%2Fmd.00000000...
      Last time updated on 17/03/2019
      Sustaining member

      Harvard University - DASH

      redirect
      oaioai:dash.harvard.edu:1/3302988...
      Last time updated on 17/04/2018

      Carolina Digital Repository

      redirect
      oaicdr.lib.unc.edu:zg64tr74k
      Last time updated on 23/04/2020